A new report from Public Citizen lays out the reasons for concern about the new coronavirus and the...
Drugs and technology
Policymakers should not allow pharmaceutical companies to win...
In a New York Times op-ed today, Azzi Momenbalighaf and Mariana Mazucato explain that Americans are...
Would the Trump administration’s plan to address insulin...
President Trump is touting a plan that he says would bring insulin costs down to $35 a month for...
Need a life-saving drug you can’t afford? Consider...
Do you or someone you love need a life-saving drug that your insurer won’t cover or you...
Real risk of medication errors at CVS and other chain pharmacies
Ellen Gabler writes for The New York Times about the risk of medication errors from using chain...
Legalization of marijuana without safeguards creates large...
Medical marijuana is now legal in 33 states and Washington D.C. Recreational marijuana is legal in...
New year brings new and higher drug prices
Surprise, surprise. Reuters reports that Pharma is ushering the new year with new and higher drug...
Lilly breaks its promise to offer lower-cost insulin
Eli Lilly may be talking the right talk when it comes to insulin prices, but it is not walking the...
Speaker Pelosi’s drug bill passes in the US House of...
Last week, the US House of Representatives passed the Elijah E. Cummings Lower Drug Costs Now Act...
Facebook, Uber and Walmart, among others, expand further into...
Health care has become such a lucrative enterprise that health care businesses are expanding and...